The Beneficence of Neonatal Hematopoiesis
- 26 October 1989
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 321 (17) , 1190-1191
- https://doi.org/10.1056/nejm198910263211710
Abstract
THE fetus and the newborn are highly endowed with the capacity to produce blood,1 and the site-specific stages and switches through which the accelerated blood production moves during development2 are becoming particularly fascinating as the regulatory proteins that influence them are identified.3 The production of red cells begins in the yolk sac only a few weeks after conception. Yolk-sac erythrocytes are very large nucleated cells that uniquely express the products of certain genes, such as embryonic globin. When hematopoiesis is completed in the yolk sac, it moves on to the liver, and that organ fills with nucleated red cells. Relatively . . .Keywords
This publication has 6 references indexed in Scilit:
- Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical SiblingNew England Journal of Medicine, 1989
- Can cord blood be used?Nature, 1989
- Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cellsNature, 1989
- Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.Proceedings of the National Academy of Sciences, 1989
- Studies of circulating hemopoietic progenitor cells in human fetal bloodBlood, 1982
- Isozymes of human phosphofructokinase: Identification and subunit structural characterization of a new systemProceedings of the National Academy of Sciences, 1980